New treatment option for Achilles Tendinopathy
Official title Effects of Low-load Resistance Training With Blood Flow Restriction in Patients With Achilles Tendinopathy
ClinicalTrials.gov ID: NCT05241197
What this study is testing
- What it's testing
- Midportion Achilles tendinopathy (MAT) is a common overuse injury of the lower extremity characterized by the presence of pain, restricted function and interruption of sport activities. Conservative management of MAT has been suggested as the first line of treatment.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50
You may be able to join if
- Clinical diagnosis of unilateral MAT.
- Achilles pain \> 3 months.
- Age ranging between 18 to 50 years, both genders.
- Read and speak Spanish well enough to provide informed consent and follow study instructions.
- Can attend in-clinic treatments 2-3 x weekly for the next 12 weeks.
You likely can't join if
- Any ankle or foot surgery.
- History of Achilles rupture.
- Heel pain in the last 3 months.
- Systemic disorders/diseases.
- History of deep venous thrombosis, hypertension or blood clotting disorder.
- Body mass index \> 30kg/m2.
See the full eligibility criteria
- Clinical diagnosis of unilateral MAT.
- Achilles pain \> 3 months.
- Age ranging between 18 to 50 years, both genders.
- Read and speak Spanish well enough to provide informed consent and follow study instructions.
- Can attend in-clinic treatments 2-3 x weekly for the next 12 weeks.
- Any ankle or foot surgery.
- History of Achilles rupture.
- Heel pain in the last 3 months.
- Systemic disorders/diseases.
- History of deep venous thrombosis, hypertension or blood clotting disorder.
- Body mass index \> 30kg/m2.
- Self-report of pregnancy.
- Drug use (local steroid injection or systemic fluoroquinolones).
- Pain \< 2/10 of average pain on NPRS.
- VISA A score \> 90%.
- Unable to perform any of the exercises of the study.
The study team makes the final eligibility decision.
Where it's taking place
- Rosario, Santa Fe Province, Argentina
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rosario, Santa Fe Province, Argentina. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.